IRBESARTAN (Hisun Pharmaceuticals USA Inc.)
Welcome to the PulseAid listing for the IRBESARTAN drug offered from Hisun Pharmaceuticals USA Inc.. This Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Hisun Pharmaceuticals USA Inc. |
NON-PROPRIETARY NAME: | IRBESARTAN |
SUBSTANCE NAME: | IRBESARTAN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-06-14 |
END MARKETING DATE: | 0000-00-00 |
IRBESARTAN HUMAN PRESCRIPTION DRUG Details:
Item Description | IRBESARTAN from Hisun Pharmaceuticals USA Inc. |
LABELER NAME: | Hisun Pharmaceuticals USA Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 75(mg/1) |
START MARKETING DATE: | 2016-06-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42658-121_35c0e2f7-e6ec-0971-e054-00144ff88e88 |
PRODUCT NDC: | 42658-121 |
APPLICATION NUMBER: | ANDA206194 |
Other IRBESARTAN Pharmaceutical Manufacturers / Labelers: